Výsledky vyhledávání - "Otilia Dumitrescu"

Autor: Markus Huber, Otilia Dumitrescu, Michael Krone, Stefan Reinhardt, Bernhard Eberhardt, Daniel Weiskopf

Publikováno v: IV

Smoothed particle hydrodynamics (SPH) is a popular mesh-free, particle-based fluid simulation approach for a wide range of applications. There are several numerical variants of SPH along with a variety of models for aspects such as boundary condition

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::22c5c447a47f7cfd5019752010c5b7dd
https://doi.org/10.1109/iv.2017.20

Zobrazit plný text záznamu

Phase I Trial of Weekly and Twice-Weekly Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Relapsed or Refractory non-Hodgkin Lymphoma

Autor: Owen A. O'Connor, Ariela Noy, Alexia Iasonos, Otilia Dumitrescu, Craig H. Moskowitz, Carol S. Portlock, Philip Schulman, John F. Gerecitano, David J. Straus, Jennifer Pappanicholaou, Celeste Rojas, Endri Horanlli, Paul A. Hamlin, Zhigang Zhang, Qianxing Mo, Debra M. Sarasohn, Andrew D. Zelenetz

Purpose: To determine the safety and efficacy of substituting weekly or twice-weekly bortezomib for vincristine in the R-CVP (rituximab, cyclophosphamide, vincristine, and prednisone) regimen in patients with relapsed/refractory indolent and mantle c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef027411da176d25bc203fc13ab6db81
https://europepmc.org/articles/PMC5639472/

Zobrazit plný text záznamu

Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes

Autor: Brenda W. Cooper, Susan Blumel, Barbara Mac-Gregor Cortelli, Andrew M. Evens, John Butos, Otilia Dumitrescu, Owen A. O'Connor, David J. Straus, Carol S. Portlock, Ellen Neylon, John F. Gerecitano, Debra M. Sarasohn, Mithat Gonen, John J. Wright, Paul A. Hamlin, Jane N. Winter, Andrew D. Zelenetz, Julie M. Vose, Craig H. Moskowitz

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 16(2)

Purpose: To determine the antitumor activity of the novel proteasome inhibitor bortezomib in patients with indolent non–Hodgkin's lymphoma. Experimental Design: Patients with follicular lymphoma (FL), marginal zone lymphoma, mantle cell lymphoma, s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6b89695d4ed8637e37d96a1183c095a
https://pubmed.ncbi.nlm.nih.gov/20068103

Zobrazit plný text záznamu

Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentre Phase 2 clinical trial

Autor: Debra M. Sarasohn, Andrew D. Zelenetz, John Butos, Craig H. Moskowitz, Leo I. Gordon, Mithat Gonen, Owen A. O'Connor, Rachel Hamelers, Barbara Mac-Gregor Cortelli, Julie M. Vose, David J. Straus, Paul A. Hamlin, Carol S. Portlock, Susan Blumel, Ellen Neylon, Brenda W. Cooper, Otilia Dumitrescu, Jane N. Winter, John J. Wright

Publikováno v: British journal of haematology. 145(1)

The recent approval of bortezomib for the treatment of mantle cell lymphoma (MCL) by the US Food and Drug Administration is based on the results of the multicentre PINNACLE study with supportive data from a number of single and multicentre Phase 2 st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7484572dc8cd908ee0c939d5b476b6d4
https://pubmed.ncbi.nlm.nih.gov/19220284

Zobrazit plný text záznamu

Pegylated interferon plus rituximab in advanced stage, indolent lymphoma: is there CD20 antigen upregulation?

Autor: Peter Maslak, Lisa Rosenzweig, Otilia Dumitrescu, David J. Straus, Carol S. Portlock, Owen A. O'Connor, Oscar Lin

Publikováno v: Leukemialymphoma. 47(7)

The anti-CD20 monoclonal antibody, rituximab, and interferon alpha (IFN) are active agents in advanced stage, indolent lymphoma. Some data obtained in vitro suggest upregulation of CD20 by IFN, and clinical trials have reported additive or synergisti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdeb22b7068958daab2a439c80e8479a
https://pubmed.ncbi.nlm.nih.gov/16923555

Zobrazit plný text záznamu

Plný text ve formátu HTML

Loculated mediastinal chylothorax resulting from esophagogastrectomy: a case report

Autor: Syma Baran, Neil Halpern, Everett M. Lautin, Jeffrey L. Lautin, Hideki Sakurai, Otilia Dumitrescu

Publikováno v: Journal of thoracic imaging. 8(4)

The thoracic duct is closely related to the esophagus and the pleura. During an esophagogastrectomy, the thoracic duct is at risk for injury, which usually results in chylous pleural effusions. We present an uncommon situation, however, where the ple

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58027f9fd0c7717a5b04cd1b2bb8ecd5
https://pubmed.ncbi.nlm.nih.gov/8246331

Zobrazit plný text záznamu

Final Results of a Phase II Study of Sequential R-CHOP and Yttrium-90 Ibritumomab Tiuxetan (RIT) for Elderly High Risk Patients with Untreated Diffuse Large B-Cell Lymphoma (DLBCL)

Autor: Maria Alma Rodriguez, Ariela Noy, Frederick B. Hagemeister, Carol S. Portlock, Peter McLaughlin, Brett Wegner, Craig H. Moskowitz, Otilia Dumitrescu, David J. Straus, Luis Fayad, Andrew D. Zelenetz, Neetha Pandit Tasker, Barbara Pro, Paul A. Hamlin

Publikováno v: Blood. 116:1793-1793

Abstract 1793 Introduction: Elderly patients (pts) with high risk DLBCL are one of the fastest growing demographics of pts, but advances over RCHOP21 have not been realized. These pts are often under-represented in clinical trial secondary to comorbi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::93aa32662441dd1fc8ed391af5343545
https://doi.org/10.1182/blood.v116.21.1793.1793

Zobrazit plný text záznamu

Early Safety and Efficacy Analysis of a Phase II Study of Sequential R-CHOP and Yttrium-90 Ibritumomab Tiuxetan (Zevalin®) for Elderly High Risk Patients with Untreated DLBCL

Autor: Neeta Pandit-Taskar, Brett Wegner, Owen A. O'Connor, Craig H. Moskowitz, Ariela Noy, Otilia Dumitrescu, Carol S. Portlock, David J. Straus, Chaitanya R. Divgi, Andrew D. Zelenetz, Paul A. Hamlin, Maria Lia Palomba, Steven M. Horwitz

Publikováno v: Blood. 106:926-926

Introduction: Elderly patients (pts) with high risk DLBCL represent an increasing demographic, are often underserved in clinical trials, and need improved therapies. By the age-adjusted international prognostic index (aaIPI), pts >60 years (yrs) with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::38c3af42cb653d12e251f1fb347a8fda
https://doi.org/10.1182/blood.v106.11.926.926

Zobrazit plný text záznamu

The Disappearing Kidney

Autor: Otilia Dumitrescu, Thomas Kahn, Ho-Soon H. Choi, Raisa Katz, Juan D. Goyzueta

Publikováno v: Archives of Internal Medicine. 154:2613

We describe a case of bilateral emphysematous pyelonephritis in which the left kidney could not be visualized sonographically because of multiple irregular air-fluid interfaces. This observation, which to our knowledge has been noted only once before

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9e01f4e38a060b39dc248201b3707c
https://doi.org/10.1001/archinte.1994.00420220113013

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání